Items where Author is "Suckling, Keith E."

Item Type No Grouping

Article

SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis. (1997) Theo Berkhout, Helen M. Simon, Brian Jackson, John Yates, Nigel Pearce, Pieter H E Groot, Craig Bentzen, Eric Niesor, William D. Kerns and Keith E. Suckling

The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. (1996) Theo Berkhout, Helen M. Simon, Dilip D. Patel, Craig Bentzen, Eric Niesor, Brian Jackson and Keith E. Suckling

Other

SKF 99085 a novel hypocholesterolemic agent with multiple anti-atherosclerotic properties, suppresses HMG-CoA reductase and induces LDL receptor activity by a novel mechanism. (1994) Theo Berkhout, H. Simon, Eric Niesor, Craig Bentzen and Keith E. Suckling